Skip to main content
The BMJ logoLink to The BMJ
letter
. 1995 May 27;310(6991):1411. doi: 10.1136/bmj.310.6991.1411a

Reperfusion injury after myocardial infarction.

B P Morgan
PMCID: PMC2549784  PMID: 7787572

Full text

PDF

Page 1411

1411

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Grech E. D., Jackson M. J., Ramsdale D. R. Reperfusion injury after acute myocardial infarction. BMJ. 1995 Feb 25;310(6978):477–478. doi: 10.1136/bmj.310.6978.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Homeister J. W., Lucchesi B. R. Complement activation and inhibition in myocardial ischemia and reperfusion injury. Annu Rev Pharmacol Toxicol. 1994;34:17–40. doi: 10.1146/annurev.pa.34.040194.000313. [DOI] [PubMed] [Google Scholar]
  3. Rossen R. D., Michael L. H., Kagiyama A., Savage H. E., Hanson G., Reisberg M. A., Moake J. N., Kim S. H., Self D., Weakley S. Mechanism of complement activation after coronary artery occlusion: evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivo. Circ Res. 1988 Mar;62(3):572–584. doi: 10.1161/01.res.62.3.572. [DOI] [PubMed] [Google Scholar]
  4. Rubin B., Smith A., Romaschin A., Walker P. Participation of the complement system in ischemia/reperfusion injury. Microcirc Endothelium Lymphatics. 1989 Jun-Oct;5(3-5):207–221. [PubMed] [Google Scholar]
  5. Weisman H. F., Bartow T., Leppo M. K., Marsh H. C., Jr, Carson G. R., Concino M. F., Boyle M. P., Roux K. H., Weisfeldt M. L., Fearon D. T. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science. 1990 Jul 13;249(4965):146–151. doi: 10.1126/science.2371562. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES